On the first day of the JPM Healthcase Conference, AbbVie announced that it would acquire the global rights outside China to ...

Eli Lilly (LLY) heads into 2026 with GLP-1 pricing and competition risks; oral GLP-1 race heats up and downside looms.

Speaking at the J.P. Morgan conference, CEO David Ricks said he anticipates a “rapid review” for orforglipron that's ...

“The dynamics of the policy changes that have occurred in the last year-plus since the Trump administration are certainly ...

Nvidia and Eli Lilly are teaming up on a $1 billion AI-powered lab to accelerate drug discovery, combining robotics, molecular modeling and automated research workflows.

The site, which will cost about €10.0 billion ($11.7 billion) to complete, will be the third-largest of the company’s Verbund ...

Jan 13 () - Global drugmakers are ramping up U. manufacturing and stockpiling inventory as the Trump administration considers ...

NVIDIA and Eli Lilly are investing US$1bn to develop an AI lab, pioneering robotics and physical AI to accelerate medicine ...

Fed Chair Jerome Powell might be the most even-keeled man in Washington. Even he couldn't let the latest Trump administration ...

An extension study of Amgen's experimental obesity drug MariTide found that it helped people maintain weight loss when given ...

ASX 200 futures are up 27pts (+0.30%) as of 8:30 am AEDT. Here's what you need to know before the market opens.